Prostate Cancer

Combining drugs for better prostate cancer treatment?

AFT-19 trial: Investigating androgen blockade intensification in prostate cancer.

New prostate cancer inhibitor holds massive promise

Cell-active inhibitor designed for methyltransferase KMT9.

UCLA unravels aggressive growth in prostate cancers, eluding treatment

Temporal evolution reveals dual lineages in prostate cancer transformation.

Cost-effective prostate cancer focal therapy benefits

Study analyzes the cost-effectiveness of focal therapy, radical prostatectomy, and radiotherapy for prostate cancer.

Advancements in aggressive prostate cancer therapy

Enzalutamide improves recurrent prostate cancer prognosis.

Turning routine vaccines into weapons against cancer

Using Salmonella to fight pancreatic cancer: How CD8 T cells can help.

11 genes linked to aggressive prostate cancer mutations

Using germline sequencing to guide prostate cancer gene panel testing.

Early breakfast linked to lower risk of type 2 Diabetes

Eating early and often may reduce your risk of Type 2 Diabetes.

A novel approach to target enhancer-addicted cancers

Potential treatment approach for over 90% of prostate cancers.

Men with large waistline are more likely to die of prostate cancer

There is a link between central adiposity and risk of death from prostate cancer.

Being active reduces the risk of prostate cancer

Prostate cancer is the most common cancer in men in the UK*, yet we still don't know all of its causes.

Scientists used computer model to predict prostate cancer progression

Other than skin cancer, prostate cancer is the most common cancer in men in the western world. About 1 man in 9 will be diagnosed...

Recent Stories